title: Why have trials of isoniazid preventive therapy among people with HIV infection not demonstrated an effect on mortality?: did close examination of the trees obscure our view of the wood?
authors.affiliation: Department of Clinical Research, Faculty of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK. alison.grant@lshtm.ac.uk
authors.forename: Alison D
authors.initials: AD
authors.lastname: Grant
authors.forename: Katherine L
authors.initials: KL
authors.lastname: Fielding
authors.forename: Salome
authors.initials: S
authors.lastname: Charalambous
authors.forename: Richard E
authors.initials: RE
authors.lastname: Chaisson
authors.forename: Gavin J
authors.initials: GJ
authors.lastname: Churchyard
mesh_terms: D023241:Antiretroviral Therapy, Highly Active / Q000401:mortality; D000995:Antitubercular Agents / Q000627:therapeutic use*; D018791:CD4 Lymphocyte Count; D015658:HIV Infections / Q000188:drug therapy* / Q000401:mortality; D015497:HIV-1; D006801:Humans; D007538:Isoniazid / Q000627:therapeutic use*; D016032:Randomized Controlled Trials as Topic; D012307:Risk Factors; D014376:Tuberculosis / Q000188:drug therapy* / Q000401:mortality; D019562:Viral Load
chemical_list: D000995:Antitubercular Agents; D007538:Isoniazid